AMAG rejects MSMB Capital unsolicited acquisition offer for $18 per share, or about $380.9M in cash

AMAG Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$334.9m on 08/05/2011 [market cap]

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

MSMB Capital Management LLC

U.S. / Financial

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Canceled

Sample

01/01/2009

announced

01/01/2009

Canceled